The PRDM8 Gene and Differential Diagnosis

Understanding the genetic cause of this condition requires looking deep into the brain’s instruction manual. While a diagnosis is often based on the symptoms you see every day, the root cause lies in the PRDM8 gene, which acts as a “master controller” for how the nervous system is built ^[1][2].

The Role of the PRDM8 Gene

The PRDM8 gene belongs to a family of chromatin regulators ^[2]. Think of your DNA like a massive library of books; chromatin is the shelving and packaging system that keeps everything organized. A chromatin regulator like PRDM8 decides which “books” (genes) are open and readable and which are closed ^[3].

Scientists are investigating PRDM8’s function through animal models. While these studies do not perfectly explain human disease progression, they offer hypotheses for several critical tasks:

• Neuronal Migration: In animal models, PRDM8 has been investigated for its role in helping new brain cells move to their correct locations in the neocortex (the outer layer of the brain) ^[4]. It may do this by acting on pathways involving genes like Ebf3 and NeuroD1, which act as a GPS for migrating cells ^[4].
• Spinal Cord Development: In zebrafish models, PRDM8 acts as a switch. It helps tell young cells whether they should become motor neurons (which control movement) or oligodendrocytes (which insulate nerve fibers) ^[5].
• Brain Structure: Research in mice shows that without functioning PRDM8, the brain’s upper layers may not develop properly, leading to a smaller brain size and growth delays ^[6].

When this gene is mutated in humans, these regulatory processes are disrupted, contributing to the symptoms of epilepsy, muscle stiffness, and cognitive changes seen in patients ^[1].

Ruling Out “Look-Alike” Conditions

Because the symptoms of PRDM8-related disorders—such as seizures, muscle jerks (myoclonus), and walking difficulties—overlap with many other rare diseases, doctors must perform a differential diagnosis. This is a process of elimination to rule out conditions that look similar on the surface but have different genetic causes.

Common conditions that doctors may consider include:

• Classic Lafora Disease: This is a common “mimic.” It is caused by mutations in the EPM2A or NHLRC1 genes ^[7].
• Unverricht-Lundborg Disease: A form of epilepsy that usually starts in late childhood and is caused by the CSTB gene ^[1].
• Neuronal Ceroid Lipofuscinoses (NCLs): Also known as Batten disease, these are lysosomal storage disorders that often involve vision loss and cognitive decline ^[8].
• MERRF Syndrome: A mitochondrial disorder that causes myoclonus, seizures, and muscle weakness ^[9].
• Neuronopathic Gaucher Disease: A rare metabolic condition that can cause neurological decline and enlarged organs ^[1].
• Hereditary Spastic Paraplegia (HSP): A group of disorders characterized by progressive leg stiffness ^[10].

Differentiating from Classic Lafora Disease

One of the clinical clues in identifying PRDM8 is what is not there. In classic Lafora disease, a skin biopsy usually shows Lafora bodies—abnormal clumps of sugar (polyglucosans) inside the cells ^[7].

In contrast, the two reported families with PRDM8 mutations had negative skin biopsies; their cells did not contain these characteristic clumps ^[1]. Additionally, PRDM8 symptoms may appear earlier in life than classic Lafora disease, which typically begins in the teenage years ^[1]. However, a negative biopsy alone isn’t enough to rule everything out, as some cases of classic Lafora can also show a negative result early on ^[11].

The Path to a Definitive Diagnosis and Genetic Counseling

Because so many conditions look alike, physical exams and biopsies can only go so far. Molecular genetic testing is the definitive way to confirm a PRDM8-related disorder ^[1].

Doctors typically use:

1. Targeted Tests or Gene Panels: A test that looks at a specific group of genes known to cause epilepsy or spasticity.
2. Whole Exome Sequencing (WES): A comprehensive test that scans almost all of the protein-coding genes in the body ^[12].

In the few families documented with this condition, Whole Exome Sequencing was the tool that helped identify the diagnosis after years of uncertainty ^[1]. If a standard panel does not find an answer, moving to WES or even Whole Genome Sequencing may be necessary to find rare or deep-seated genetic changes ^[13][14].

An important step is genetic counseling. A genetic counselor will explain whether the genetic change is pathogenic (disease-causing) or a Variant of Uncertain Significance (VUS). A VUS alone does not confirm the diagnosis and requires further clinical correlation. The counselor will also discuss the inheritance pattern, implications for carrier status, and whether family testing is recommended.